Pharma Journalist -

Eisai Co., Ltd. and Bristol-Myers Squibb Company announced that the companies have entered into an exclusive global strategic collaboration agreement for the co-development and…
Read More...

Horizon Therapeutics plc announced that it has reached an agreement to purchase a drug product manufacturing facility from EirGen Pharma, an OPKO Health Company (Nasdaq: OPK) in…
Read More...

Kite, a Gilead Company and Shoreline Biosciences, Inc. (Shoreline), a biotechnology company developing intelligently designed allogeneic off-the-shelf, standardized and targeted natural…
Read More...

https://vimeo.com/563272966 At Online Seminar we know that in an era of increasing digital complexity you still want to connect with your target audience. Whether you communicate…
Read More...

Pfizer Inc.  and The Academic Research Organization (ARO) from the Hospital Israelita Albert Einstein today announced that the New England Journal of Medicine has published positive…
Read More...

Novartis announced that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation (BTD) to 177Lu-PSMA-617, an investigational radioligand therapy for the…
Read More...

SMi reports: Discussions will be centered around improving targeted therapy uniting the field’s biggest players to share their opinions From optimizing particle size to choosing the…
Read More...

SMi Reports: Workshop will include case studies related to emergent digital health innovations currently coming out of Silicon Valley, software apps connected to drug delivery…
Read More...

Lumen Bioscience, a clinical-stage biopharmaceutical company developing biologic drugs for highly prevalent diseases, announce it has entered into a research collaboration with Novo…
Read More...

United Therapeutics Corporation  announced that the U.S. Food and Drug Administration (FDA) accepted for priority review the New Drug Application (NDA) for Tyvaso DPI™ (inhaled…
Read More...